Actively Recruiting
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Led by University of California, San Francisco · Updated on 2026-03-17
12
Participants Needed
4
Research Sites
636 weeks
Total Duration
On this page
Sponsors
U
University of California, San Francisco
Lead Sponsor
M
METAvivor Research and Support, Inc
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a prospective observational registry for patients with invasive lobular carcinoma (ILC) of the breast. After the first 1cohort is enrolled, the collected data will be utilized to develop an ILC specific response assessment tool.
CONDITIONS
Official Title
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically confirmed invasive lobular carcinoma, including mixed lobular/ductal cancer
- Age 18 years or older
- Any receptor subtype
- Ability to understand and willing to sign informed consent
You will not qualify if you...
- Stage I-III breast cancer
- Tumor biopsy lacking lobular histology
- Presence of other active cancer (prior treated cancer with no current evidence of disease is allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of California, San Diego
San Diego, California, United States, 92053
Actively Recruiting
2
University of California, San Francisco
San Francisco, California, United States, 94122
Actively Recruiting
3
Abramson Cancer Center
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
4
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
A
Astrid Quirarte
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here